Study shows angiotensin-converting enzyme 2 decoy protein as a promising anti-SARS-CoV-2 agent
In a recent study posted to the bioRxiv* preprint server, researchers presented a microbody recombinant decoy protein with high affinity ...
In a recent study posted to the bioRxiv* preprint server, researchers presented a microbody recombinant decoy protein with high affinity ...
To address the overdose crisis in the United States, the National Institutes of Health has established a research network that ...
Shenandoah Biotechnology Inc., a FUJIFILM Irvine Scientific company and leading manufacturer of recombinant proteins, today announced it has expanded its ...
The liver’s ability to regenerate itself is legendary. Even if more than 70 percent of the organ is removed, the ...
A study published in the journal Science Translational Medicine has described the transmissibility of severe acute respiratory syndrome coronavirus 2 ...
In a recent study published in the Journal of Antimicrobial Chemotherapy, researchers developed an antibiotic resistance (ABR) awareness scale to...
Read moreSome labs publish new papers every month and get millions in grant money. How do they do it? No, it’s...
Read moreRemotely controlled miniature biological robots — biobots — have many potential applications in medicine, sensing and environmental monitoring. Researchers at...
Read moreTurning a decades-old dogma on its head, new research from scientists at UC San Francisco and Stanford Medicine shows that...
Read more© 2022 Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.